Hyperuricemia — an independent factor for the progression of chronic kidney disease
Journal Title: Нирки - Year 2017, Vol 6, Issue 2
Abstract
Objective of the research — to evaluate the efficacy of combined hypouricemic therapy in patients with hyperuricemia, urate nephropathy on the background of concomitant pathology (type 2 diabetes mellitus, hypertension) based on the dynamics of uricemia, uricosuria, the functional state of the kidneys, minimizing and eliminating the risk factors for the progression of chronic kidney disease. Sixty seven patients were involved in the study. Correction of hyperuricemia in patients with urate nephropathy and concomitant pathology (type 2 diabetes mellitus, hypertension) using phytodiuretic agent Urolesan® in combination treatment leads to normalization of metabolic processes, improvement of glomerular filtration rate, and a decrease in the level of albumin excretion.
Authors and Affiliations
M. D. Tronko, M. N. Dolzhenko, S. V. Kushnirenko, V. L. Orlenko, O. O. Shevchuk
Keywords
Related Articles
- EP ID EP208844
- DOI 10.22141/2307-1257.6.2.2017.102787
- Views 85
- Downloads 0
ABO-incompatible kidney transplantation: historical aspects and actual ways of solving the problem (literature review)
.
New era of dialysis: expanded haemodialysis (HDx)
The article is addressed to practical physicians involved in renal replacement therapy, mainly haemodialysis (HD). The article presents a new method for haemodialysis — expanded haemodialysis, assesses its efficiency, an...
Hemostatic System and its Regulation in Disorders of Renal Function
In various violations of kidney function, there is a change in the hemostatic system, which can manifest itself in the form of thrombosis or bleedings. In these processes, vascular endothelium, platelets, plasma proteins...
Kidney Aspects of the Lung Cancer
Metastases in the kidney, perirenal retroperitoneal lymph nodes and adrenal glands occur in 2, 2, and 3 % of patients with lung cancer, respectively, and acute tubulointerstitial nephritis develops in 6 % of cases of rad...
Changes in Renal Vascular Endothelium and Indicators of Endothelial Vascular Dysfunction in Systemic Autoimmune Rheumatic Diseases
Background. The renal endothelium is the primary barrier which reacts to systemic endothelial vascular dysfunction in patients with rheumatic diseases. The objective of the work was to evaluate the nature of morphologica...